Civil Rights
Block on Trump's Asylum Ban Upheld by Supreme Court
The Federal Trade Commission (FTC) has filed complaints in four separate cases alleging that weight-loss and weight-control claims were not supported by competent and reliable scientific evidence. Marketers of the four products (Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart) have settled with the FTC, surrendered cash and other assets worth at least $25 million, and agreed to limit their future advertising claims. "You won't find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient," said FTC Chairman Deborah Platt Majoras. "Paying for fad science is a good way to lose cash, not pounds."
Sign into your Legal Forms and Services account to manage your estate planning documents.
Sign InCreate an account allows to take advantage of these benefits: